NASDAQ:HQY HealthEquity (HQY) Stock Forecast, Price & News $65.38 -0.29 (-0.44%) (As of 06/7/2023 ET) Add Compare Share Share Today's Range$64.74▼$66.9450-Day Range$51.02▼$65.6752-Week Range$48.86▼$79.20Volume992,972 shsAverage Volume559,991 shsMarket Capitalization$5.59 billionP/E RatioN/ADividend YieldN/APrice Target$80.91 ProfileProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial MediaProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial Media HealthEquity MarketRank™ ForecastAnalyst RatingModerate Buy2.78 Rating ScoreUpside/Downside25.9% Upside$82.33 Price TargetShort InterestBearish3.88% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.37Based on 30 Articles This WeekInsider TradingN/AProj. Earnings Growth50.98%From $1.02 to $1.54 Per ShareSee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.2.28 out of 5 starsMedical Sector251st out of 981 stocksBusiness Services, Not Elsewhere Classified Industry41st out of 90 stocks 3.4 Analyst's Opinion Consensus RatingHealthEquity has received a consensus rating of Buy. The company's average rating score is 2.75, and is based on 6 buy ratings, 2 hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $82.33, HealthEquity has a forecasted upside of 25.9% from its current price of $65.38.Amount of Analyst CoverageHealthEquity has only been the subject of 2 research reports in the past 90 days. Previous Next 2.0 Short Interest Percentage of Shares Shorted3.88% of the float of HealthEquity has been sold short.Short Interest Ratio / Days to CoverHealthEquity has a short interest ratio ("days to cover") of 4.9.Change versus previous monthShort interest in HealthEquity has recently increased by 1.27%, indicating that investor sentiment is decreasing. Previous Next 0.0 Dividend Strength Dividend YieldHealthEquity does not currently pay a dividend.Dividend GrowthHealthEquity does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for HQY. Previous Next 3.0 News and Social Media Coverage News SentimentHealthEquity has a news sentiment score of 0.37. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.51 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 30 news articles for HealthEquity this week, compared to 5 articles on an average week.Search Interest9 people have searched for HQY on MarketBeat in the last 30 days. MarketBeat Follows9 people have added HealthEquity to their MarketBeat watchlist in the last 30 days. Previous Next 1.7 Company Ownership Insider Buying vs. Insider SellingIn the past three months, HealthEquity insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 2.70% of the stock of HealthEquity is held by insiders.Percentage Held by Institutions99.54% of the stock of HealthEquity is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 1.9 Earnings and Valuation Earnings GrowthEarnings for HealthEquity are expected to grow by 50.98% in the coming year, from $1.02 to $1.54 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of HealthEquity is -653.80, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of HealthEquity is -653.80, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Growth RatioHealthEquity has a PEG Ratio of 2.73. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioHealthEquity has a P/B Ratio of 2.92. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About HealthEquity (NASDAQ:HQY) StockHealthEquity, Inc. engages in the provision of technology-enabled services for healthcare and spending decisions. The company was founded by Stephen D. Neeleman on September 18, 2002 and is headquartered in Draper, UT.Read More Receive HQY Stock News and Ratings via Email Sign-up to receive the latest news and ratings for HealthEquity and its competitors with MarketBeat's FREE daily newsletter. Email Address HQY Stock News HeadlinesJune 7, 2023 | markets.businessinsider.comSVB Securities Keeps Their Buy Rating on Healthequity (HQY)June 7, 2023 | msn.comRBC Capital Reiterates Healthequity (HQY) Prior RecommendationJune 8, 2023 | Behind the Markets (Ad)BREAKING: Tiny biotech successfully treats blindnessThere's a tiny biotech in Cambridge that's using a breakthrough technology to treat blindness. This company has already shown success in human trials... And Our research shows that anyone who gets in today could see a 46,751% return.June 6, 2023 | benzinga.comWhy HealthEquity Stock Is Up TodayJune 6, 2023 | msn.comStocks making the biggest moves midday: Coinbase, GitLab, HealthEquity and moreJune 6, 2023 | finance.yahoo.comWhy Shares of HealthEquity Are Up TuesdayJune 6, 2023 | americanbankingnews.comResearch Analysts Issue Forecasts for HealthEquity, Inc.'s Q2 2024 Earnings (NASDAQ:HQY)June 5, 2023 | seekingalpha.comHealthEquity Non-GAAP EPS of $0.50 beats by $0.09, revenue of $244.43M beats by $4.13MJune 8, 2023 | Behind the Markets (Ad)The single greatest medical breakthrough of all time?We are on the cusp of a medical breakthrough. And soon, this single breakthrough could lead to the cure of over 6,000 genetic diseases, including Alzheimer's, heart disease, and even cancer! This reminds me of Amgen, where early investors made as much as 46,751% when they released their revolutionary drug to the market.June 5, 2023 | msn.comRecap: HealthEquity Q1 EarningsJune 5, 2023 | chron.comHealthEquity: Fiscal Q1 Earnings SnapshotJune 5, 2023 | finance.yahoo.comHealthEquity (HQY) Q1 Earnings and Revenues Surpass EstimatesJune 5, 2023 | finance.yahoo.comHealthEquity (HQY) Reports Q1 Earnings: What Key Metrics Have to SayJune 5, 2023 | americanbankingnews.comHealthEquity (NASDAQ:HQY) vs. LiveWorld (OTCMKTS:LVWD) Critical ContrastJune 4, 2023 | msn.comHealthEquity Q1 2024 Earnings PreviewJune 3, 2023 | americanbankingnews.comHealthEquity (HQY) Set to Announce Earnings on MondayJune 2, 2023 | msn.comEarnings Preview For HealthEquityJune 2, 2023 | finance.yahoo.comWhy HealthEquity (HQY) is a Top Growth Stock for the Long-TermJune 2, 2023 | americanbankingnews.comQ1 2026 EPS Estimates for HealthEquity, Inc. (NASDAQ:HQY) Increased by AnalystJune 1, 2023 | msn.comBarrington Research Reiterates Healthequity (HQY) Outperform RecommendationJune 1, 2023 | msn.comThe Latest Analyst Ratings for HealthEquityMay 21, 2023 | americanbankingnews.comHealthEquity (NASDAQ:HQY) Earns Hold Rating from Analysts at StockNews.comMay 19, 2023 | americanbankingnews.comAnalysts Set HealthEquity, Inc. (NASDAQ:HQY) PT at $80.91May 10, 2023 | americanbankingnews.comHealthEquity (NASDAQ:HQY) versus Relx (NYSE:RELX) Head-To-Head SurveyMay 9, 2023 | finance.yahoo.comHealthEquity Honored with 2023 Healthy Worksite Award by Utah Worksite Wellness CouncilMay 8, 2023 | finance.yahoo.comHealthEquity Sets Date to Announce First Quarter Results Presentation at ConferencesMay 8, 2023 | finance.yahoo.comHealthEquity Sets Date to Announce First Quarter Results Presentation at ConferencesSee More Headlines HQY Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart HQY Company Calendar Last Earnings3/21/2023Today6/08/2023Next Earnings (Estimated)9/05/2023Fiscal Year End1/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry Business services, not elsewhere classified Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:HQY CUSIPN/A CIK1428336 Webwww.healthequity.com Phone(801) 727-1000Fax801-727-1005Employees3,208Year FoundedN/APrice Target and Rating Average Stock Price Forecast$82.33 High Stock Price Forecast$94.00 Low Stock Price Forecast$71.00 Forecasted Upside/Downside+23.8%Consensus RatingModerate Buy Rating Score (0-4)2.78 Research Coverage8 Analysts Profitability EPS (Most Recent Fiscal Year)($0.10) Trailing P/E RatioN/A Forward P/E Ratio64.10 P/E Growth3.05Net Income$-26,140,000.00 Net Margins-0.93% Pretax Margin-1.11% Return on Equity4.30% Return on Assets2.65% Debt Debt-to-Equity Ratio0.45 Current Ratio4.00 Quick Ratio2.92 Sales & Book Value Annual Sales$861.75 million Price / Sales6.48 Cash Flow$2.70 per share Price / Cash Flow24.23 Book Value$22.45 per share Price / Book2.91Miscellaneous Outstanding Shares85,470,000Free Float83,162,000Market Cap$5.59 billion OptionableOptionable Beta0.78 Key ExecutivesJon KesslerPresident, Chief Executive Officer & DirectorAngelique HillExecutive Vice President-OperationsTyson MurdockChief Financial Officer & Executive Vice PresidentElimelech RosnerChief Technology Officer & Executive VPJody DietelSenior Vice President-Compliance & Regulatory NewsKey CompetitorsPhreesiaNYSE:PHRGlobus MedicalNYSE:GMEDOption Care HealthNASDAQ:OPCHNateraNASDAQ:NTRAQuidelOrthoNASDAQ:QDELView All CompetitorsInsiders & InstitutionsMacquarie Group Ltd.Sold 21,870 shares on 6/1/2023Ownership: 0.042%Prelude Capital Management LLCSold 9,170 shares on 6/1/2023Ownership: 0.008%ProShare Advisors LLCSold 2,367 shares on 5/26/2023Ownership: 0.017%Putnam Investments LLCBought 29,183 shares on 5/22/2023Ownership: 0.275%Ameriprise Financial Inc.Sold 36,146 shares on 5/22/2023Ownership: 0.265%View All Insider TransactionsView All Institutional Transactions HQY Stock - Frequently Asked Questions Should I buy or sell HealthEquity stock right now? 8 Wall Street analysts have issued "buy," "hold," and "sell" ratings for HealthEquity in the last year. There are currently 2 hold ratings and 6 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" HQY shares. View HQY analyst ratings or view top-rated stocks. What is HealthEquity's stock price forecast for 2023? 8 brokerages have issued 12-month target prices for HealthEquity's stock. Their HQY share price forecasts range from $71.00 to $94.00. On average, they predict the company's share price to reach $82.33 in the next twelve months. This suggests a possible upside of 25.9% from the stock's current price. View analysts price targets for HQY or view top-rated stocks among Wall Street analysts. How have HQY shares performed in 2023? HealthEquity's stock was trading at $61.64 on January 1st, 2023. Since then, HQY shares have increased by 6.1% and is now trading at $65.38. View the best growth stocks for 2023 here. When is HealthEquity's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Tuesday, September 5th 2023. View our HQY earnings forecast. How were HealthEquity's earnings last quarter? HealthEquity, Inc. (NASDAQ:HQY) released its quarterly earnings data on Tuesday, March, 21st. The company reported $0.26 earnings per share for the quarter, topping the consensus estimate of $0.20 by $0.06. The business had revenue of $233.84 million for the quarter, compared to the consensus estimate of $229.43 million. HealthEquity had a positive trailing twelve-month return on equity of 4.30% and a negative net margin of 0.93%. What ETFs hold HealthEquity's stock? ETFs with the largest weight of HealthEquity (NASDAQ:HQY) stock in their portfolio include Motley Fool Mid-Cap Growth ETF (TMFM), Putnam Sustainable Future ETF (PFUT), Global X FinTech Thematic ETF (FINX), SPDR S&P Health Care Services ETF (XHS), MFAM Small-Cap Growth ETF (MFMS), Motley Fool Small-Cap Growth ETF (TMFS), Nuveen Small Cap Select ETF (NSCS) and iShares U.S. Healthcare Providers ETF (IHF). What guidance has HealthEquity issued on next quarter's earnings? HealthEquity issued an update on its FY 2024 earnings guidance on Wednesday, June, 7th. The company provided earnings per share (EPS) guidance of $1.88-$1.97 for the period, compared to the consensus EPS estimate of $1.77. The company issued revenue guidance of $975.00 million-$985.00 million, compared to the consensus revenue estimate of $967.94 million. What is Jon Kessler's approval rating as HealthEquity's CEO? 359 employees have rated HealthEquity Chief Executive Officer Jon Kessler on Glassdoor.com. Jon Kessler has an approval rating of 95% among the company's employees. This puts Jon Kessler in the top 30% of approval ratings compared to other CEOs of publicly-traded companies. 69.0% of employees surveyed would recommend working at HealthEquity to a friend. What other stocks do shareholders of HealthEquity own? Based on aggregate information from My MarketBeat watchlists, some companies that other HealthEquity investors own include NVIDIA (NVDA), Shopify (SHOP), Block (SQ), Okta (OKTA), PayPal (PYPL), Twilio (TWLO), Trade Desk (TTD), Alibaba Group (BABA), Casino, Guichard-Perrachon Societe Anonyme (COP) and Input Capital (INP). What is HealthEquity's stock symbol? HealthEquity trades on the NASDAQ under the ticker symbol "HQY." Who are HealthEquity's major shareholders? HealthEquity's stock is owned by a number of retail and institutional investors. Top institutional investors include BlackRock Inc. (12.13%), Wasatch Advisors LP (9.10%), FMR LLC (5.34%), William Blair Investment Management LLC (3.39%), State Street Corp (3.24%) and JPMorgan Chase & Co. (2.90%). Insiders that own company stock include Adrian T Dillon, Angelique Christine Hill, Ashley Dreier, Darcy G Mott, Darcy G Mott, Debra Charlotte Mccowan, Delano Ladd, Edward Bloomberg, Frank Corvino, Frank Medici, Gayle Furgurson Wellborn, Ian Sacks, Jon Kessler, Larry L Trittschuh, Stuart B Parker and William Robert Otten. View institutional ownership trends. How do I buy shares of HealthEquity? Shares of HQY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is HealthEquity's stock price today? One share of HQY stock can currently be purchased for approximately $65.38. How much money does HealthEquity make? HealthEquity (NASDAQ:HQY) has a market capitalization of $5.59 billion and generates $861.75 million in revenue each year. The company earns $-26,140,000.00 in net income (profit) each year or ($0.10) on an earnings per share basis. How many employees does HealthEquity have? The company employs 3,208 workers across the globe. How can I contact HealthEquity? HealthEquity's mailing address is 15 WEST SCENIC POINTE DRIVE SUITE 100, DRAPER UT, 84020. The official website for the company is www.healthequity.com. The company can be reached via phone at (801) 727-1000, via email at rputnam@healthequity.com, or via fax at 801-727-1005. This page (NASDAQ:HQY) was last updated on 6/8/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding HealthEquity, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.